The very first, leading, highly popular, free and CME-Accredited Online Course titled “Longevity Medicine 101. Introduction to Longevity Medicine”, was developed collaboratively between leading Artificial Intelligence (AI) professionals, practicing physicians, biogerontology experts, and geroscientists, to provide the first credible source of Longevity Medicine Education to train and upskill the healthcare professionals of the future. With this initiative, this course will now be available in Portuguese and Spanish on the Teachable platform for free. Longevity Medicine 201 – the advanced course, will also be translated and narrated in both languages in early 2023.
Longevity Medicine is defined as a branch of precision medicine that is specifically focused on promoting and optimizing human’s health span by targeting the aging process across our lifespan, intensively powered by AI technology.
The concepts covered in the courses have been published in journals such as Nature Aging and Lancet Healthy Longevity, introducing key foundations for the growth of this field such as: “Artificial Intelligence in Longevity Medicine” “ and Longevity medicine: upskilling the physicians of tomorrow”.
The course provides a comprehensive Longevity Medicine curriculum for clinicians, scientists and healthcare professionals, covering topics around biogerontology, geroscience, and AI-based medicine, as well as a broad foundation of translational aging research terminology, theories and hallmarks of aging, basic aging pathways and mechanisms behind potential geroprotective interventions, various types of aging clocks and more.
Kickstarted and authored by the interdisciplinary team led by Alex Zhavoronkov, Ph.D., from Insilico Medicine, Evelyne Bischof, MD, of Renji Hospital Jiaotong University and Human Longevity Inc San Diego/Beijing, Alexey Moskalev, Ph.D., of the Russian Academy of Sciences and Morten Scheibye-Knudsen, MD, Ph.D., of the University of Copenhagen, the Longevity Medicine Course was launched on a public educational platform in December 2020, with over 2,700 learners registering immediately. In July 2021 the Course transitioned to the Longevity Degree platform and received the Continuing Medical Education (CME) accreditation from the Medical Society of Delaware (MSD). The courses are currently under review by EACCME – European Accreditation Council for Continuing Medical Education to grant the European CME Accreditation for all European Countries. So far, over 5000 learners from over 80 countries having taken the course since its launch.
Longevity Education Hub will be actively contributing to evolve this important field of medicine, hereby making the courses and materials readily accessible to the broad medical community. The Portuguese and Spanish National Chapters will soon include other languages and so further accelerate the knowledge of course takers from all over the world in this specialized and exciting developing field.
"It is a true joy to see the rapid expansion of our Longevity Medicine Course for Physicians through national chapters. Next to English and Chinese, two additional of the most spoken languages around the world – Portuguese & Spanish - have now been added, to facilitate the learning experience of our students”, Evelyne Bischof, MD, Longevity Physician and Professor of Clinical Medicine at the Shanghai University of Medicine.
“Longevity Medicine has become a truly international discipline. The number of Portuguese and Spanish-speaking medical professionals is very substantial. I am very happy to see the Longevity Medicine courses launching in Spanish and Portuguese.” Alex Zhavoronkov, PhD, Insilico Medicine.
“It is a true pleasure to be part of this great team of professionals and join forces to spread this fundamental training for daily medical practice." Carolina Hernández, director of education and professor at the University of Barcelona.
“The National Chapter initiative and the launch of the Portuguese and Spanish courses will democratize access to next-generation medical education for healthcare professionals that are interested in Longevity Medicine and that would like to contribute to the future of this medical specialty” Ricardo Gaminha Pacheco, MD, MBA, Longevity and Pharmaceutical Medicine Physician Executive.